NVWM LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.4K | Sell |
103
-5,980
| -98% | -$325K | ﹤0.01% | 376 |
|
|
2026
Q1 | $382K | Buy |
6,083
+363
| +6% | +$29K | 0.09% | 182 |
|
|
2025
Q4 | $545K | Sell |
5,720
-4,347
| -43% | -$426K | 0.12% | 170 |
|
|
2025
Q3 | $983K | Sell |
10,067
-61
| -0.6% | -$6.32K | 0.22% | 130 |
|
|
2025
Q2 | $1.09M | Buy |
10,128
+10,087
| +24,602% | +$1.02M | 0.26% | 116 |
|
|
2025
Q1 | $4.14K | Sell |
41
-92
| -69% | -$9.26K | ﹤0.01% | 331 |
|
|
2024
Q4 | $11.9K | Hold |
133
| – | – | ﹤0.01% | 291 |
|
|
2024
Q3 | $11.1K | Hold |
133
| – | – | ﹤0.01% | 296 |
|
|
2024
Q2 | $10.2K | Sell |
133
-235
| -64% | -$17.2K | ﹤0.01% | 303 |
|
|
2024
Q1 | $25.2K | Sell |
368
-65
| -15% | -$4.18K | 0.01% | 255 |
|
|
2023
Q4 | $25K | Hold |
433
| – | – | 0.01% | 262 |
|
|
2023
Q3 | $22.9K | Hold |
433
| – | – | 0.01% | 270 |
|
|
2023
Q2 | $23.4K | Buy |
433
+250
| +137% | +$13.1K | 0.01% | 287 |
|
|
2023
Q1 | $9.15K | Sell |
183
-92
| -33% | -$4.34K | ﹤0.01% | 348 |
|
|
2022
Q4 | $12.7K | Hold |
275
| – | – | ﹤0.01% | 311 |
|
|
2022
Q3 | $11K | Hold |
275
| – | – | ﹤0.01% | 323 |
|
|
2022
Q2 | $10K | Hold |
275
| – | – | ﹤0.01% | 342 |
|
|
2022
Q1 | $12K | Hold |
275
| – | – | ﹤0.01% | 363 |
|
|
2021
Q4 | $12K | Hold |
275
| – | – | ﹤0.01% | 367 |
|
|
2021
Q3 | $12K | Hold |
275
| – | – | ﹤0.01% | 345 |
|
|
2021
Q2 | $12K | Hold |
275
| – | – | ﹤0.01% | 322 |
|
|
2021
Q1 | $11K | Hold |
275
| – | – | ﹤0.01% | 306 |
|
|
2020
Q4 | $10K | Hold |
275
| – | – | ﹤0.01% | 287 |
|
|
2020
Q3 | $11K | Hold |
275
| – | – | 0.01% | 265 |
|
|
2020
Q2 | $10K | Hold |
275
| – | – | 0.01% | 246 |
|
|
2020
Q1 | $9K | Sell |
275
-418
| -60% | -$16.3K | 0.01% | 236 |
|
|
2019
Q4 | $31K | Hold |
693
| – | – | 0.02% | 197 |
|
|
2019
Q3 | $28K | Hold |
693
| – | – | 0.02% | 226 |
|
|
2019
Q2 | $30K | Sell |
693
-15,226
| -96% | -$586K | 0.02% | 226 |
|
|
2019
Q1 | $611K | Buy |
15,919
+558
| +4% | +$21.3K | 0.4% | 81 |
|
|
2018
Q4 | $543K | Buy |
15,361
+1,705
| +12% | +$61.8K | 0.41% | 79 |
|
|
2018
Q3 | $526K | Buy |
13,656
+341
| +3% | +$11.9K | 0.33% | 97 |
|
|
2018
Q2 | $435K | Buy |
+13,315
| New | +$402K | 0.3% | 104 |
|
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$25K | – | 332 |
|
|
2017
Q4 | $25K | Buy |
+1,000
| New | +$27.6K | 0.02% | 201 |
|
Other funds holding BSX
NVWM LLC's BSX Position: Q2 2026 in Review
NVWM LLC reduced its Boston Scientific (BSX) stake by 98% in Q2 2026, selling an estimated $325K and leaving 103 shares worth $4.4K. The position accounts for ﹤0.01% of the portfolio, ranked #376.
NVWM LLC first reported a position in BSX in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.09M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- NVWM LLC held 103 shares of Boston Scientific worth $4.4K as of Q2 2026.
- NVWM LLC sold 5,980 Boston Scientific shares in Q2 2026, an estimated $325K.
- Boston Scientific made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #376 holding.
- NVWM LLC first reported a position in Boston Scientific in Q4 2017 and has held it in 34 quarters since.
- NVWM LLC's Boston Scientific position peaked at $1.09M in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.